We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Survival Rates Improve for Infant Heart Surgery

By HospiMedica staff writers
Posted on 27 Nov 2000
A study has found that survival rates have been steadily improving for infants who undergo surgery for hypoplastic left heart syndrome (HLHS), a life-threatening congenital condition. More...
The study reported on 840 infants operated on for HLHS at the Children's Hospital of Philadelphia (PA, USA) and was published in a November supplement of Circulation.

HLHS is the second-most common congenital heart defect presenting in the first week of life, and without surgery is invariably fatal. Currently, surgery is performed in three stages: the first on newborns, the second at about six months of age, and a third--the Fontan procedure--between one and two years of age. Researchers found that rates for hospital survival after the first stage improved from 56% in 1984-1989 to 71% in 1995-1998. Even better, survival rates for January 1999 through April 2000 showed an 86% survival rate.

The improved survival rates are the result of refinements in surgical techniques and in the pre-and post-surgical management of children with HLHS. Two other contributing factors were the introduction of the intermediate surgical procedure in 1989 and the increased experience of surgeons.

"Until now, relatively litle has been known about longer-term survival of patients with HlHS, but our study shows very few late deaths among patients discharged after the third stage,” said William Mahle, M.D., attending cardiologist at the Cardiac Center of The Children's Hospital.



Related Links:
Children's Hospital of Philadelphia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.